Cargando…
Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample
BACKGROUND: Growing evidence supports the validity of distinguishing major depressive disorder (MDD) plus a lifetime history of subthreshold hypomania (D(m)) from pure MDD in psychiatric classifications. The present study sought to estimate the proportion of individuals with D(m) that would have bee...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566200/ https://www.ncbi.nlm.nih.gov/pubmed/23405152 http://dx.doi.org/10.1371/journal.pone.0055448 |
_version_ | 1782258553483952128 |
---|---|
author | Hoertel, Nicolas Le Strat, Yann Limosin, Frédéric Dubertret, Caroline Gorwood, Philip |
author_facet | Hoertel, Nicolas Le Strat, Yann Limosin, Frédéric Dubertret, Caroline Gorwood, Philip |
author_sort | Hoertel, Nicolas |
collection | PubMed |
description | BACKGROUND: Growing evidence supports the validity of distinguishing major depressive disorder (MDD) plus a lifetime history of subthreshold hypomania (D(m)) from pure MDD in psychiatric classifications. The present study sought to estimate the proportion of individuals with D(m) that would have been included in RCTs for MDD using typical eligibility criteria, and examine the potential impact of including these participants on internal validity. METHODS: Data were derived from the 2001–2002 National Epidemiological Survey on Alcohol and Related Conditions (NESARC), a national representative sample of 43,093 adults of the United States population. We examined the proportion of participants with a current diagnosis of pure MDD and D(m) that would have been eligible in clinical trials for MDD with a traditional set of eligibility criteria, and compared it with that of participants with bipolar 2 disorder if the same set of eligibility criteria was applied. We considered 4 models including different definitions of subthreshold hypomania. RESULTS: We found that more than 7 out of ten participants with pure MDD and with D(m) would have been excluded by at least one classical eligibility criterion. Prevalence rate of individuals with D(m) in RCTs for MDD with traditional eligibility criteria would have ranged from 7.98% to 22.59%. Overall exclusion rate of individuals with MDD plus at least 4 lifetime concomitant hypomanic probes significantly differ from those with pure MDD, whereas it was not significantly different in those with at least 2 lifetime concomitant hypomanic probes compared to those with bipolar 2 disorder. CONCLUSIONS: The current design of clinical trials for MDD may suffer from impaired external validity and potential impaired internal validity, due to the inclusion of a substantial proportion of individuals with subthreshold hypomania presenting with similar pattern of exclusion rates to those with bipolar 2 disorder, possibly resulting in a selection bias. |
format | Online Article Text |
id | pubmed-3566200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35662002013-02-12 Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample Hoertel, Nicolas Le Strat, Yann Limosin, Frédéric Dubertret, Caroline Gorwood, Philip PLoS One Research Article BACKGROUND: Growing evidence supports the validity of distinguishing major depressive disorder (MDD) plus a lifetime history of subthreshold hypomania (D(m)) from pure MDD in psychiatric classifications. The present study sought to estimate the proportion of individuals with D(m) that would have been included in RCTs for MDD using typical eligibility criteria, and examine the potential impact of including these participants on internal validity. METHODS: Data were derived from the 2001–2002 National Epidemiological Survey on Alcohol and Related Conditions (NESARC), a national representative sample of 43,093 adults of the United States population. We examined the proportion of participants with a current diagnosis of pure MDD and D(m) that would have been eligible in clinical trials for MDD with a traditional set of eligibility criteria, and compared it with that of participants with bipolar 2 disorder if the same set of eligibility criteria was applied. We considered 4 models including different definitions of subthreshold hypomania. RESULTS: We found that more than 7 out of ten participants with pure MDD and with D(m) would have been excluded by at least one classical eligibility criterion. Prevalence rate of individuals with D(m) in RCTs for MDD with traditional eligibility criteria would have ranged from 7.98% to 22.59%. Overall exclusion rate of individuals with MDD plus at least 4 lifetime concomitant hypomanic probes significantly differ from those with pure MDD, whereas it was not significantly different in those with at least 2 lifetime concomitant hypomanic probes compared to those with bipolar 2 disorder. CONCLUSIONS: The current design of clinical trials for MDD may suffer from impaired external validity and potential impaired internal validity, due to the inclusion of a substantial proportion of individuals with subthreshold hypomania presenting with similar pattern of exclusion rates to those with bipolar 2 disorder, possibly resulting in a selection bias. Public Library of Science 2013-02-06 /pmc/articles/PMC3566200/ /pubmed/23405152 http://dx.doi.org/10.1371/journal.pone.0055448 Text en © 2013 Hoertel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hoertel, Nicolas Le Strat, Yann Limosin, Frédéric Dubertret, Caroline Gorwood, Philip Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title | Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title_full | Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title_fullStr | Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title_full_unstemmed | Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title_short | Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample |
title_sort | prevalence of subthreshold hypomania and impact on internal validity of rcts for major depressive disorder: results from a national epidemiological sample |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566200/ https://www.ncbi.nlm.nih.gov/pubmed/23405152 http://dx.doi.org/10.1371/journal.pone.0055448 |
work_keys_str_mv | AT hoertelnicolas prevalenceofsubthresholdhypomaniaandimpactoninternalvalidityofrctsformajordepressivedisorderresultsfromanationalepidemiologicalsample AT lestratyann prevalenceofsubthresholdhypomaniaandimpactoninternalvalidityofrctsformajordepressivedisorderresultsfromanationalepidemiologicalsample AT limosinfrederic prevalenceofsubthresholdhypomaniaandimpactoninternalvalidityofrctsformajordepressivedisorderresultsfromanationalepidemiologicalsample AT dubertretcaroline prevalenceofsubthresholdhypomaniaandimpactoninternalvalidityofrctsformajordepressivedisorderresultsfromanationalepidemiologicalsample AT gorwoodphilip prevalenceofsubthresholdhypomaniaandimpactoninternalvalidityofrctsformajordepressivedisorderresultsfromanationalepidemiologicalsample |